graphy a few years ago, or nuclear magnetic resonance scanning today) should be installed only in institutions able to evaluate them properly and with catchment areas adequate to provide the sort of patients to whom the new techniques will be applied when they become available to the average district general hospital. No new treatment (for example, coronary artery bypass grafting in patients without symptoms) should be allowed except as part of a properly conducted clinical trial, and such a trial would have to be conducted on a multicentre basis so that a wide variety of patients and medical skill would be included. Before they can be approved for prescription on a large scale new drugs need to be tested not only for efficacy but also in comparison with old drugs; a new and expensive drug can be accepted only if it is superior to an older and cheaper one. Training in evaluation techniques must form part of the education of any potential consultant; only by so doing will consultants carry through their career the habit of inquiry and scepticism that will be essential in the more restricted financial atmosphere that lies ahead.
Clinical freedom died accidentally, crushed between the rising cost of new forms of investigation and treatment and the financial limits inevitable in an economy that cannot expand indefinitely. Clinical freedom should, however, have been strangled long ago, for at best it was a cloak for ignorance and at worst an excuse for quackery. Clinical freedom was a myth that prevented true advance. We must welcome its demise, and seize the opportunities now laid out before us. Nuclear medicine in district general hospitals
Artificially produced radioactive isotopes were one of the benefits that came from research on atomic energy in the second world war. In medicine they were initially used in biochemical and biological research, but by the early 1950s various diagnostic investigations had been introduced, notably in the assessment of thyroid function and in haematology. At the same time radioactive iodine was introduced for the treatment of thyrotoxicosis and some thyroid cancers, and radioactive phosphorus became available for the treatment of polycythaemia rubra vera and leukaemia.1 At that time simple external scanning procedures were available to delineate the anatomical form of the thyroid gland.
Next came more complex equipment, the rectilinear scanner and later the gammacamera, which gave much more rapid and precise information. The advent of the artificial radioactive isotope technetium-99m made scanning simpler, accurate, and safe. Brain, liver, bone, and lung scanning were soon developed, and nuclear medicine can be said to have been launched as a specialty by the end ofthe decade. The greatest impetus for these and subsequent clinical developments occurred in the United States, with contributions from Europe, Australia, and Japan, where active departments of nuclear medicine emerged. In Britain, however, the pattern and extent of development were slow and very haphazard, though notable advances were made by a few individuals. With nuclear medicine established as a specialty plans were clearly needed for the organisation of nuclear medicine services throughout the country-and various plans are still being produced and debated more than 20 years later. In 1970 a report by the Department of Health and Social Services (the Windeyer report)2 recommended that each region should have a major nuclear medicine centre, from which services could be provided or supervised throughout hospitals in the rest of the region. This was never implemented, and in any event the specialty advanced so rapidly that it would not have been practicable, though some of the underlying thoughts are still pertinent. The Royal Colleges of Physicians of Edinburgh and London, and the Royal College of Physicians and Surgeons of Glasgow have considered the subject on three occasions since 1971, looking at the training needs and defining the scope of nuclear medicine as a specialty. Their second report in 1975 strongly recommended that nuclear medicine departments should be under the charge of properly trained clinicians3 and calculated that about 80 would be needed over the next few years-at a time when over 1200 physicians in the United States were wholly practising nuclear medicine. The consultants in charge, said the colleges, would need to work harmoniously with non-medical scientists, notably physicists, chemists, and pharmacists, because nuclear medicine is more than most a multidisciplinary specialty. These proposals were widely accepted but were put into effect only in some parts of the country; in many localities arrangements are still far from satisfactory. Advice on future training programmes was given, and a specialist advisory committee in nuclear medicine was set up. The proposals recognised and welcomed the fact that clinicians from several disciplines might be interested in training for nuclear medicine, but most were expected to come from general medicine or radiology. Already, however, the numbers in training were out of step with the planned vacancies; in the mid-1970s there were too few senior registrars to fill the modest needs of the time, yet those who were trained a few years later were unable to get consultant posts because area health authorities could not afford to create them-a state of affairs that continues.
Croft4 summarised the scene in Britain in 1979 with particular respect to nuclear medicine facilities in district general hospitals, which were and still are inadequate. For an adequate service at this level he envisaged the training of either physicians who would be able to provide a comprehensive service, or radiologists who would provide just an imaging service, both on a roughly half time basis. His views and arguments have stimulated and been elaborated in a third report from the previous three royal colleges, this time in col-laboration with the Royal College of Radiologists.5 This refreshingly clear and concise report emphasises the vital part that nuclear medicine now plays in good medical practice and recommends that facilities should be made available in all district general hospitals if optimal medical care is to be available uniformly throughout the country.
Facilities should be centralised under a properly trained clinician, who should have spent two years' training in a recognised department, says the report. It considers he should give about half his time to the specialty and be either a general physician, who could encompass the whole range of nuclear medicine techniques, or a radiologist, who would supervise nuclear medicine imaging and who would be well placed to integrate this with both old and the newer radiological methods and with ultrasound. In both instances help from non-medical scientists would be needed, not necessarily all on site. The intercollegiate report also gives sensible advice on training and accreditation of the clinician and-thank goodness-considers that no new examination is needed in nuclear medicine.
Financial restraints will make all this difficult to implement, as they have done for a decade, but nevertheless the report points out (and several precise financial details are given) that the cost of these services is comparable with conventional radiological techniques and considerably cheaper than others, such as computed tomography and coronary angiography.
No practising physician or surgeon would deny the need for such a service in every district general hospital. There seems to be a place, however, for more flexibility than envisaged in this report. The whole range of nuclear medicine services is now available in most of the tcaching centres in Britain, but in some these are fragmented and not yet under the direction of a fully trained consultant. This can be rectified as the present directors, mostly non-medical scientists, retire. Nevertheless, a similar comprehensive service is needed in all the other major medical centres, mostly in cities. These usually have a radiotherapy centre and other subregional specialties and ideally what they now need is a clinician who would give substantially all his time to nuclear medicine. Such fully committed consultants would require four years' training in the specialty as envisaged in this and the earlier intercollegiate report.
In district general hospitals in smaller towns, by contrast, a radiologist trained in nuclear medicine would be the better option. In these hospitals there is no reason why simple non-imaging function tests and radioimmunoassay measurements should not continue to be performed in other laboratories. These and the imaging service could be supported by the nearest comprehensive centre, a theme originally suggested by the Windeyer report but only hinted at in the last intercollegiate report.
With such a scheme the nuclear medicine consultant in the major centre could help his colleagues by providing general guidance and skill, arrange regular clinical meetings, and perform the more elaborate investigations. Physicists would advise on equipment and its management and give authoritative guidance on radiation protection-something that constantly worries technicians and nurses handling the smallest quantities of radionuclides. The comprehensive centre could also provide supplies of less often used and more expensive radiopharmaceuticals and give other help from the radiopharmacist. Indeed, in some instances all the non-medical scientists and technicians might be based on and be interchangeable with their counterparts at the major centre.
The continuing failure by the DHSS to implement the sensible recommendations of these intercollegiate reports is largely due to financial restraints related to the strategic philosophy of the National Health Service in the past 10 years. Much is also due, however, to the hand to mouth manner in which the NHS is run, with its rigid establishments and failure to welcome the numerous advances in medical science. Whereas in a proper "service" a suitable clinician would be specifically chosen and seconded for training, this does not happen in the NHS, certainly not in district general hospitals.
It is all the more important, therefore, for hospital and regional medical committees to foresee the need for a specialist in nuclear medicine some time before the next retirement is due, and to plan accordingly. And let us hope that in a few years this important specialty, which has now come of age, will be fully integrated into NHS hospitals-and that further intercollegiate reports will be unnecessary. 
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